465 related articles for article (PubMed ID: 23731998)
41. Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: A systematic review and meta-analysis.
Raiman M; Mitchell CG; Biccard BM; Rodseth RN
Eur J Anaesthesiol; 2016 Jan; 33(1):42-8. PubMed ID: 26351826
[TBL] [Abstract][Full Text] [Related]
42. Effects of hydroxyethyl starch administration on renal function in critically ill patients.
Sakr Y; Payen D; Reinhart K; Sipmann FS; Zavala E; Bewley J; Marx G; Vincent JL
Br J Anaesth; 2007 Feb; 98(2):216-24. PubMed ID: 17251213
[TBL] [Abstract][Full Text] [Related]
43. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
Perel P; Roberts I
Cochrane Database Syst Rev; 2007 Oct; (4):CD000567. PubMed ID: 17943746
[TBL] [Abstract][Full Text] [Related]
44. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.
Zarychanski R; Abou-Setta AM; Turgeon AF; Houston BL; McIntyre L; Marshall JC; Fergusson DA
JAMA; 2013 Feb; 309(7):678-88. PubMed ID: 23423413
[TBL] [Abstract][Full Text] [Related]
45. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.
Hand WR; Whiteley JR; Epperson TI; Tam L; Crego H; Wolf B; Chavin KD; Taber DJ
Anesth Analg; 2015 Mar; 120(3):619-626. PubMed ID: 25036375
[TBL] [Abstract][Full Text] [Related]
46. Fluid replacement with hydroxyethyl starch in critical care--a reassessment.
Hartog CS; Welte T; Schlattmann P; Reinhart K
Dtsch Arztebl Int; 2013 Jun; 110(26):443-50. PubMed ID: 23885279
[TBL] [Abstract][Full Text] [Related]
47. Individual patient data comparative analysis of hydroxyethyl starch 130/0.4 v 4% albumin for fluid resuscitation in critically ill patients: statistical analysis plan.
Hammond NE; Billot L; Finfer S; Myburgh J
Crit Care Resusc; 2014 Sep; 16(3):206-13. PubMed ID: 25161024
[TBL] [Abstract][Full Text] [Related]
48. [The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock].
Lyu J; Li T; Liu F; An Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):28-32. PubMed ID: 25591433
[TBL] [Abstract][Full Text] [Related]
49. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
Roberts I; Alderson P; Bunn F; Chinnock P; Ker K; Schierhout G
Cochrane Database Syst Rev; 2004 Oct; (4):CD000567. PubMed ID: 15495001
[TBL] [Abstract][Full Text] [Related]
50. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
Crit Care Resusc; 2017 Sep; 19(3):239-246. PubMed ID: 28866974
[TBL] [Abstract][Full Text] [Related]
51. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
Müller RB; Haase N; Lange T; Wetterslev J; Perner A
Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
[TBL] [Abstract][Full Text] [Related]
52. Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta-analysis.
Martin GS; Bassett P
J Crit Care; 2019 Apr; 50():144-154. PubMed ID: 30540968
[TBL] [Abstract][Full Text] [Related]
53. Normal saline for intravenous fluid therapy in critically ill patients.
Zhou FH; Liu C; Mao Z; Ma PL
Chin J Traumatol; 2018 Feb; 21(1):11-15. PubMed ID: 29429774
[TBL] [Abstract][Full Text] [Related]
54. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
[TBL] [Abstract][Full Text] [Related]
55. Hydroxyethyl Starch for Fluid Management in Patients Undergoing Major Abdominal Surgery: A Systematic Review With Meta-analysis and Trial Sequential Analysis.
Pensier J; Deffontis L; Rollé A; Aarab Y; Capdevila M; Monet C; Carr J; Futier E; Molinari N; Jaber S; De Jong A
Anesth Analg; 2022 Apr; 134(4):686-695. PubMed ID: 34854822
[TBL] [Abstract][Full Text] [Related]
56. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
[TBL] [Abstract][Full Text] [Related]
57. Effect of Hydroxyethyl Starch on Outcomes in High-Risk Vascular Surgery Patients: A Retrospective Analysis.
Green RS; Butler MB; Hicks SD; Erdogan M
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):967-72. PubMed ID: 27222051
[TBL] [Abstract][Full Text] [Related]
58. Hydroxyethyl starch and acute kidney injury in high-risk patients undergoing cardiac surgery: A prospective multicenter study.
Nagore D; Candela A; Bürge M; Monedero P; Tamayo E; Alvarez J; Murie M; Wijeysundera Dn DN; Vives M;
J Clin Anesth; 2021 Oct; 73():110367. PubMed ID: 34090184
[TBL] [Abstract][Full Text] [Related]
59. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
Dart AB; Mutter TC; Ruth CA; Taback SP
Cochrane Database Syst Rev; 2010 Jan; (1):CD007594. PubMed ID: 20091640
[TBL] [Abstract][Full Text] [Related]
60. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
Trials; 2015 Aug; 16():384. PubMed ID: 26314293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
